- Design
- systematic review with meta-analyses, stratified by immersion depth and mechanism, GRADE certainty
- Population
- 12 trials in knee osteoarthritis and 9 after total knee arthroplasty; samples 36 to 306, follow-up mostly 3 months or less
- Primary outcome
- pain-related functioning and pain intensity
- Effect
- osteoarthritis pain-related functioning SMD −0.59 (95% CI −1.11 to −0.06); post-arthroplasty pain intensity SMD −0.12 (−0.75 to 0.52)
A systematic review searched to December 2025 for trials of extended reality in knee osteoarthritis or recovery after total knee arthroplasty, and — unusually — stratified them by depth of immersion and clinical mechanism rather than lumping every headset and app together. Twelve trials addressed osteoarthritis and nine addressed post-arthroplasty recovery, with samples from 36 to 306 and follow-up mostly three months or less.
For knee osteoarthritis, interactive digital rehabilitation — guided exercise with feedback, not full immersion — improved pain-related functioning (pooled SMD −0.59, 95% CI −1.11 to −0.06, k = 5) and reduced pain intensity at six to eight weeks (SMD −0.46, −0.92 to 0.00, k = 4), both at low certainty. After arthroplasty the same approach improved pain-related functioning but made little difference to pain intensity (SMD −0.12, −0.75 to 0.52, k = 3). Virtual reality digitally augmented exercise was inconsistent throughout. No adverse event signal was found for interactive digital rehabilitation, though only five studies reported adverse events at all.
The authors' conclusion is appropriately unequal: interactive digital rehabilitation may be ready to integrate into osteoarthritis care, while its use after arthroplasty needs more evidence. That distinction matters commercially as well as clinically — these products are sold as one category.
- Consider a guided digital rehabilitation programme as an adjunct in knee osteoarthritis, not a replacement for physiotherapy
- Do not extend the osteoarthritis evidence to post-arthroplasty rehabilitation
- Ask what a product actually delivers — guided exercise with feedback, or immersive virtual reality
- Check follow-up duration before believing a durability claim; most trials stopped at three months
- Note that adverse events were barely reported, so safety is assumed rather than established
Why it matters
It separates a category that is marketed as one thing into an intervention that works and several that have not been shown to.
The statistics, in plain English
An SMD of −0.59 is a moderate effect, but the prediction interval runs from −1.72 to 0.55, meaning a future trial could plausibly find no benefit at all. The pain intensity confidence interval touching exactly 0.00 is a result that is statistically borderline, not a clear effect.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for orthopaedics, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free